J70.2

Acute drug-induced interstitial lung disorders

Billable / specific

J70.2 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.

Inclusion terms

Note: When a respiratory condition is described as occurring in more than one site and is not specifically indexed, it should be classified to the lower anatomic site (e.g. tracheobronchitis to bronchitis in J40).

Not coded here — never report together with this code.

Not included here — may be reported together when both conditions exist.

certain conditions originating in the perinatal period (P04-P96) (from J70)
certain infectious and parasitic diseases (A00-B99) (from J70)
complications of pregnancy, childbirth and the puerperium (O00-O9A) (from J70)
congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) (from J70)
endocrine, nutritional and metabolic diseases (E00-E88) (from J70)
injury, poisoning and certain other consequences of external causes (S00-T88) (from J70)
neoplasms (C00-D49) (from J70)
smoke inhalation (T59.81-) (from J70)
symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) (from J70)
asthma (J45.-) (from J70)
malignant neoplasm of bronchus and lung (C34.-) (from J70)

Add a code to identify the following, if applicable.

code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
code, where applicable, to identify: (from J70)
exposure to environmental tobacco smoke (Z77.22) (from J70)
exposure to tobacco smoke in the perinatal period (P96.81) (from J70)
history of tobacco dependence (Z87.891) (from J70)
occupational exposure to environmental tobacco smoke (Z57.31) (from J70)
tobacco dependence (F17.-) (from J70)
tobacco use (Z72.0) (from J70)